Direct-Acting Antiviral Agents for Hepatitis C Virus Infection—From Drug Discovery to Successful Implementation in Clinical Practice

Today, hepatitis C virus infection affects up to 1.5 million people per year and is responsible for 29 thousand deaths per year. In the 1970s, the clinical observation of unclear, transfusion-related cases of hepatitis ignited scientific curiosity, and after years of intensive, basic research, the h...

Descripción completa

Detalles Bibliográficos
Autores principales: Dietz, Christopher, Maasoumy, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231290/
https://www.ncbi.nlm.nih.gov/pubmed/35746796
http://dx.doi.org/10.3390/v14061325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231290/
https://www.ncbi.nlm.nih.gov/pubmed/35746796
http://dx.doi.org/10.3390/v14061325

Ejemplares similares